Summaries of Court Actions

FDA Consumer, September 1999 | Go to article overview
Save to active project

Summaries of Court Actions


SEIZURE ACTIONS

Food/Contamination, Spoilage, Insanitary Handling

PRODUCT: Shrimp, frozen, 1,493 cases, more or less, at Brownsville, Texas (S.D. Tex.); Civil Action No. B-95-017.

CHARGED 1-27-95: While held for sale after shipment in interstate commerce at Tex-Mex Cold Storage, Inc., in Brownsville, Texas, the article of food was adulterated in that it consisted in whole or in part of decomposed shrimp.

DISPOSITION: The article was destroyed. (F.D.C. No. 67036; S. No. 94-666-541; S.J. No. 1)

Drugs/Human Use

PRODUCT: Oxygen, at Sandusky, Ohio (N.D. Ohio); Civil Action No. 3:97CV7704.

CHARGED 10-28-97: While held for sale after shipment of one or more of its components in interstate commerce at Seeley Medical, Inc., in Sandusky, Ohio, the article of drug was adulterated in that the methods used in and the facilities and controls used for its manufacture, processing, packing, and holding did not conform to and were not operated and administered in conformity with current good manufacturing practice--501(a)(2)(B). The article of drug was misbranded in that its labeling failed to bear the statement "Caution: Federal law prohibits dispensing without prescription"--503(b)(4).

DISPOSITION: The article was reconditioned. FDA costs were paid and bond was released. (F.D.C. No. 67205; S. No. 97-765-575; S.J. No. 2)

PRODUCT: Oxygen, Liquid Medical, at Cumberland, Md. (D. Md.); Civil Action No. CCB 98-3410.

CHARGED 10-9-98: While held for sale after shipment of one or more of its components in interstate commerce at American Homepatient, Inc., in Cumberland, Md., the article of drug was adulterated in that the methods used in and the facilities and controls used for its manufacture, processing, packing, and holding were not in conformity with current good manufacturing practice--501(a)(2)(B).

DISPOSITION: The article of drug was reconditioned. Costs of supervision and court costs and fees were paid and bond released. (F.D.C. No. 67250; S. No. 98-716-198; S.J. No. 3)

Medical Devices

PRODUCT: Excimer Laser System, at Orlando, Fla. (M.D. Fla.); Civil Action No. 97-982-CIV-ORL-19.

CHARGED 8-8-97: The article of device, in possession of Dr. Albert Neumann at the Neumann Eye Institute, Inc., in Orlando, Fla., was adulterated because it was a Class III device under 21 U.S.C. Section 360c(f)(1), which was required to have in effect either an approved application for premarket approval (PMA) under 21 U.S.C. Section 360e, or an approved investigational device exemption (IDE) under 21 U.S.C. Section 360j(g), and no such PMA or IDE was in effect--501(f)(1)(B).

DISPOSITION: The article was destroyed. (F.D.C. No. 67192; S. No. 97-711-978; S.J. No. 4)

PRODUCT: One Excimer Laser System, at Atlanta, Ga. (N.D. Ga.); Civil Action No. 1:97-CV-1811-JOF.

CHARGED 6-24-97: The article of device, in the possession of Woodhams Eye Clinic, in Atlanta, Ga., was adulterated because it was a Class III device under 21 U.S.C. Section 360c(f)(1), and there was no approved application for premarket approval in effect pursuant to 21 U.S.C. Section 360e and no investigational device exemption was in effect pursuant to 21 U.S.C. Section 360j(g)--501(f)(1)(B).

DISPOSITION: The article was destroyed. (F.D.C. No. 67193; S. No. 96-720-783; S.J. No. 5)

Drugs/Veterinary Use

PRODUCT: Animal Drugs, at Redmond, Wash. (W.D. Wash.); Civil Action No. C94-1120C.

CHARGED 7-29-94: While held for sale after shipment of one or more of their components in interstate commerce at Argent Chemical Laboratories, Inc., in Redmond, Wash., the articles of drug were adulterated in that the methods used in and the facilities and controls used for their manufacture, processing, packing, and holding did not conform to or, upon inspection, failed to conform to, and were not operated and administered in conformity with current good manufacturing practice--501(a)(2)(B).

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

Summaries of Court Actions
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?